Tech Company Financing Transactions
Patara Pharma Funding Round
On 10/13/2015, Patara Pharma raised $33 million in Series A investment from private investors.
Transaction Overview
Company Name
Announced On
10/13/2015
Transaction Type
Debt
Venture Equity
Venture Equity
Amount
$33,000,000
Round
Series A
Investors
Proceeds Purpose
The company will use the funds from the financing to evaluate its lead candidate, PA101B, in multiple indications, including for refractory chronic cough and indolent systemic mastocytosis.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
11455 El Camino Real 460
San Diego, CA 92130
USA
San Diego, CA 92130
USA
Phone
Website
Email Address
Overview
Patara Pharma is a clinical stage biotechnology company developing new therapeutics that target debilitating allergic and inflammatory diseases and conditions in orphan or focused patient populations.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
William Gerhart
Chief Financial Officer
Leslie Schulze
Chief Medical Officer
Ahmet Tutuncu
Chief Technical Officer
Pravin Soni
VP - Regulatory Affairs
Matthew Moran
Browse more venture capital transactions:
Prev: 10/13/2015: Househappy.org venture capital transaction
Next: 10/14/2015: Luxendo venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs